Constellium SE (CSTM) Key Metrics
CSTM valuation today
Trailing 12 months · as of October 18, 2026- Market cap
- $3.45B
- Enterprise value
- $5.14B
- P/E (TTM)
- 6.6
- Forward P/E
- 8.2
- PEG ratio
- 0.40
- Price / sales
- 0.4
- Price / book
- 2.7
- EV / EBITDA
- 4.2
- Dividend yield
- —
- Beta
- 1.57
CSTM key metrics, 2024–2025
Fiscal year ended December 31, 2025 · U.S. dollarsCSTM valuation Price multiples at each fiscal year-end price.
CSTM returns How much profit the business earns on the capital it uses.
CSTM per-share figures Results divided by the shares outstanding at year-end.
CSTM financial health Debt, liquidity and how easily interest is covered.
CSTM efficiency & capital use Working capital cycle and where the cash goes.
CSTM valuation history
CSTM returns on capital
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
CSTM debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
CSTM cash returned to shareholders
CSTM price vs earnings per share
CSTM key metrics
2024–2025| 2025 | 2024 | |
|---|---|---|
| Valuation | ||
| Market capitalization | $2.68B | $1.51B |
| Enterprise value | $4.50B | $3.31B |
| P/E ratio | 9.8 | 28.0 |
| Price / sales | 0.3 | 0.2 |
| Price / book | 2.8 | 2.1 |
| Price / free cash flow | 16.8 | — |
| Price / operating cash flow | 5.5 | 5.2 |
| EV / sales | 0.5 | 0.5 |
| EV / EBITDA | 5.3 | 6.3 |
| EV / free cash flow | 28.3 | — |
| Earnings yield | 10.2% | 3.6% |
| Free cash flow yield | 5.9% | −7.1% |
| Shareholder yield (dividends + buybacks) | 4.3% | 5.0% |
| Share price at fiscal year-end | $18.85 | $10.27 |
| Per share | ||
| Revenue per share | $59.52 | $48.04 |
| Earnings per share | $1.92 | $0.37 |
| Operating cash flow per share | $3.44 | $1.97 |
| Free cash flow per share | $1.12 | −$0.73 |
| Cash per share | $0.85 | $0.96 |
| Book value per share | $6.70 | $4.79 |
| Tangible book value per share | $5.75 | $3.82 |
| Capex per share | $2.32 | $2.71 |
| Debt per share | $13.69 | $13.12 |
| Shares outstanding | 141.9M | 147.4M |
| Change in shares outstanding | −3.7% | — |
| Returns & profitability | ||
| Return on equity (ROE) | 32.9% | 7.7% |
| Return on invested capital (ROIC) | 12.1% | 5.3% |
| Return on assets (ROA) | 5.4% | 1.1% |
| Return on tangible assets | 5.2% | 1.2% |
| Free cash flow margin | 1.9% | −1.5% |
| Income quality (OCF / net income) | 1.79 | 5.38 |
| Financial health | ||
| Total debt | $1.94B | $1.94B |
| Cash & short-term investments | $120.0M | $141.0M |
| Net debt | $1.82B | $1.79B |
| Debt / equity | 2.04 | 2.74 |
| Debt / assets | 0.36 | 0.41 |
| Net debt / EBITDA | 2.14 | 3.43 |
| Current ratio | 1.29 | 1.27 |
| Quick ratio | 0.51 | 0.45 |
| Interest coverage | 4.2 | 2.3 |
| Working capital | $523.8M | $388.0M |
| Invested capital | $2.78B | $2.50B |
| Tangible asset value | $835.7M | $584.0M |
| Net current asset value | −$2.06B | −$2.17B |
| Graham number | $17.03 | $6.29 |
| Graham net-net per share | −$21.25 | −$19.74 |
| Capital allocation | ||
| Share buybacks (net) | $115.0M | $76.3M |
| Dividends + buybacks / free cash flow | 72.3% | — |
| Capex / revenue | 3.9% | 5.6% |
| Capex / operating cash flow | 67.5% | 137.2% |
| Capex / depreciation | 1.00 | 1.36 |
| Stock-based compensation / revenue | — | 0.3% |
| R&D / revenue | 0.6% | 0.7% |
| SG&A / revenue | 3.9% | 4.4% |
| Efficiency | ||
| Days sales outstanding | 26.1 | 25.0 |
| Days of inventory on hand | 62.2 | 69.8 |
| Days payables outstanding | 63.3 | 56.7 |
| Cash conversion cycle (days) | 25.0 | 38.2 |
| Receivables turnover | 13.98 | 14.57 |
| Payables turnover | 5.77 | 6.44 |
| Inventory turnover | 5.87 | 5.23 |
| Asset turnover | 1.68 | 1.50 |
| Average receivables | $604.4M | $486.0M |
| Average payables | $1.32B | $959.0M |
| Average inventory | $1.29B | $1.18B |
| Intangibles / total assets | 2.5% | 3.0% |
Computed from CSTM's annual financial statements (latest annual report filed February 25, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.
CSTM valuation and financial ratios
At the end of fiscal 2025 (December 31, 2025), Constellium traded at 9.8 times earnings. Based on the latest twelve months, the trailing P/E is 6.6 and the forward P/E is 8.2. Constellium earned a return on equity of 32.9% and a return on invested capital of 12.1% in fiscal 2025. It ended the year with $1.9 billion of debt and $120.0 million in cash and short-term investments, net debt of $1.8 billion. It returned $115.0 million to shareholders: $0 in dividends and $115.0 million in share buybacks, 72% of free cash flow.
See the CSTM income statement, the CSTM chart for price history, or the CSTM stock overview for the latest quote and news.
CSTM key metrics FAQ
What is Constellium's P/E ratio?
Constellium's trailing P/E ratio is 6.6 based on the last twelve months of earnings (as of October 18, 2026), and its forward P/E is 8.2. At the end of fiscal 2025 it was 9.8.
What is Constellium's EV/EBITDA?
Constellium's enterprise value was 5.3 times EBITDA at the end of fiscal 2025 (enterprise value $4.5 billion, EBITDA $852.0 million); the current EV/EBITDA is 4.2.
What is Constellium's return on equity?
Constellium's return on equity (ROE) was 32.9% in fiscal 2025: net income of $273.0 million on average shareholders' equity of $828.9 million.
What is Constellium's ROIC?
Constellium's return on invested capital was 12.1% in fiscal 2025, using after-tax operating income divided by average debt plus equity minus cash.
How much debt does Constellium have?
Constellium had total debt of $1.9 billion at the end of fiscal 2025, a debt-to-equity ratio of 2.04 and $1.8 billion of net debt (2.14 times EBITDA).
Does Constellium buy back its shares?
Yes. Constellium spent $115.0 million on net share repurchases in fiscal 2025 Shares outstanding changed −3.7% over the year, to 141.9M..
What is Constellium's free cash flow yield?
Constellium generated $159.0 million of free cash flow in fiscal 2025, a free cash flow yield of 5.9% on its market value at year-end ($2.7 billion).
What is Constellium's current ratio?
Constellium's current ratio was 1.29 at the end of fiscal 2025: current assets were 1.29 times current liabilities.